SCHEMBL16479516

SCHEMBL16479516

Nc1ncnn2c(C3O[C@H](CO)[C@@H](O)[C@H]3F)ccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLRMT O00411 1/20 0.40
▸ HIF1A Q16665 2/20 0.38
▸ ADORA3 P0DMS8 3/20 0.38
▸ ADORA2A P29274 2/20 0.38
▸ ADORA1 P30542 2/20 0.38
▸ PDE2A O00408 1/20 0.38
▸ ADRA1A P35348 1/20 0.38
▸ PDE4D Q08499 1/20 0.38
▸ PDE3A Q14432 1/20 0.38
▸ DOT1L Q8TEK3 3/20 0.37
▸ GAPDH P04406 2/20 0.37
▸ DPP4 P27487 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ SLC28A1 O00337 1/20 0.37
▸ MAP3K7 O43318 1/20 0.37
▸ SLC28A2 O43868 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ ADORA2B P29275 1/20 0.37
▸ STAT6 P42226 1/20 0.37
▸ PI4KA P42356 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19101901 1.00 POLRMT (0.40) POLRMTHIF1AADORA3ADORA2AADORA1
SCHEMBL806951 1.00 POLRMT (0.40) POLRMTHIF1AADORA3ADORA2AADORA1
SCHEMBL18481207 0.92 POLRMT (0.39) POLRMTHIF1AADORA3ADORA2AADORA1
SCHEMBL10154369 0.89 HIF1A (0.46) POLRMTHIF1AADORA3ADORA2AADORA1
SCHEMBL19101808 0.89 HIF1A (0.46) POLRMTHIF1AADORA3ADORA2AADORA1
SCHEMBL24982409 0.89 HIF1A (0.46) POLRMTHIF1AADORA3ADORA2AADORA1
SCHEMBL16710417 0.89 HIF1A (0.46) POLRMTHIF1AADORA3ADORA2AADORA1
SCHEMBL25008855 0.89 HIF1A (0.46) POLRMTHIF1AADORA3ADORA2AADORA1
SCHEMBL24982322 0.89 HIF1A (0.46) POLRMTHIF1AADORA3ADORA2AADORA1
SCHEMBL10101549 0.87 POLRMT (0.36) POLRMTHIF1ADOT1LGAPDHHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210393659-A1 METHODS FOR TREATING ARENAVIRIDAE AND CORONAVIRIDAE VIRUS INFECTIONS GILEAD SCIENCES, INC. 2021-12-23 — — US disclosed
US-20140200188-A1 2'-FLUORO SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT GILEAD SCIENCES, INC. 2014-07-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140200188-A1 2'-FLUORO SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT PNP, NSUN2, SLC29A2 POLRMT 101/4885HIF1A 1979/4885ADORA3 67/4885
US-20210393659-A1 METHODS FOR TREATING ARENAVIRIDAE AND CORONAVIRIDAE VIRUS INFECTIONS ACE, PNP, ACE2 POLRMT 1645/4885HIF1A 1731/4885ADORA3 3037/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback